Sartorius Stedim Biotech SA (DIM) – Strategy, SWOT and Corporate Finance Report

Sartorius Stedim Biotech SA (DIM) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification, and cell cultivation. Its major products include laboratory balances, OEM weigh cells, mass comparators, weight sets, lab water systems, pipettes, fermentators, moisture analyzers, filters, bioreactors, shakers, virus purification kits and centrifuges, among others. SSB’s services include bioprocess development and engineering, protein expression systems, media and process, instrument and validation services. The company’s products find application in the production process of medicines in biopharmaceutical and pharmaceutical industries. SSB sells products through direct sales force in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. SSB is headquartered in Aubagne, France.

Scope

• Detailed information on Sartorius Stedim Biotech SA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Sartorius Stedim Biotech SA in the form of a SWOT analysis

• An in-depth view of the business model of Sartorius Stedim Biotech SA including a breakdown and examination of key business segments

• News about Sartorius Stedim Biotech SA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Sartorius Stedim Biotech SA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Sartorius Stedim Biotech SA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Sartorius Stedim Biotech SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Danaher Corp

Qiagen Marseille SA

Thermo Fisher Scientific Inc

Bio-Rad Laboratories Inc

Merck KGaA

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Sartorius Stedim Biotech SA - Key Facts

Sartorius Stedim Biotech SA - Key Employees

Sartorius Stedim Biotech SA - Key Employee Biographies

Sartorius Stedim Biotech SA - Major Products and Services

Sartorius Stedim Biotech SA - History

Sartorius Stedim Biotech SA - Company Statement

Sartorius Stedim Biotech SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Sartorius Stedim Biotech SA - Business Description

Geographical Segment: Americas

Performance

Geographical Segment: Asia-Pacific

Performance

Geographical Segment: EMEA

Performance

R&D Overview

Sartorius Stedim Biotech SA - Corporate Strategy

Sartorius Stedim Biotech SA - SWOT Analysis

SWOT Analysis - Overview

Sartorius Stedim Biotech SA - Strengths

Sartorius Stedim Biotech SA - Weaknesses

Sartorius Stedim Biotech SA - Opportunities

Sartorius Stedim Biotech SA - Threats

Sartorius Stedim Biotech SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Sartorius Stedim Biotech SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 20, 2023: Sartorius Stedim Biotech announces first-quarter results 2023

Mar 27, 2023: Sartorius Stedim Biotech SA: René Fáber takes over as Chief Executive Officer of Sartorius Stedim Biotech S.A. Joachim Kreuzburg remains Chairman of the Board

Mar 15, 2023: Teknova and Sartorius BIA Separations Announce Collaboration to Address Critical Pain Point in Gene Therapy Process Development

Aug 09, 2022: Sartorius to acquire UK’s Albumedix for $501.5m

Jul 21, 2022: Sartorius Stedim Biotech of Half-year results 2022

Apr 21, 2022: Sartorius Stedim Biotech Announces First-quarter results 2022

Feb 17, 2022: Sartorius Stedim Biotech presents annual report for 2021

Jan 27, 2022: Preliminary results 2021 of Sartorius Stedim Biotech

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Sartorius Stedim Biotech SA, Key Facts

Sartorius Stedim Biotech SA, Key Employees

Sartorius Stedim Biotech SA, Key Employee Biographies

Sartorius Stedim Biotech SA, Major Products and Services

Sartorius Stedim Biotech SA, History

Sartorius Stedim Biotech SA, Subsidiaries

Sartorius Stedim Biotech SA, Key Competitors

Sartorius Stedim Biotech SA, Ratios based on current share price

Sartorius Stedim Biotech SA, Annual Ratios

Sartorius Stedim Biotech SA, Annual Ratios (Cont…1)

Sartorius Stedim Biotech SA, Annual Ratios (Cont…2)

Sartorius Stedim Biotech SA, Interim Ratios

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Type, 2017 to YTD 2023

Sartorius Stedim Biotech SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Sartorius Stedim Biotech SA, Performance Chart (2018 – 2022)

Sartorius Stedim Biotech SA, Ratio Charts

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals By Year, 2017 to YTD 2023

Sartorius Stedim Biotech SA, Pharmaceuticals & Healthcare, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports